Enanta Pharmaceuticals (ENTA)
(Delayed Data from NSDQ)
$12.07 USD
-0.77 (-6.00%)
Updated Jun 17, 2024 03:59 PM ET
After-Market: $12.10 +0.03 (0.25%) 7:58 PM ET
3-Hold of 5 3
C Value B Growth C Momentum C VGM
Brokerage Reports
0 items in cart
Enanta Pharmaceuticals, Inc. [ENTA]
Reports for Purchase
Showing records 161 - 164 ( 164 total )
Company: Enanta Pharmaceuticals, Inc.
Industry: Medical - Drugs
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Enanta Pharmaceuticals, Inc.
Industry: Medical - Drugs
We are initiating coverage of Enanta Pharmaceuticals, Inc. with a Buy rating
Provider: Roth Capital Partners, Inc.
Analyst: RAHIMI Y
Company: Enanta Pharmaceuticals, Inc.
Industry: Medical - Drugs
NASH Weekly Newsletter: NASH News Flow From JP Morgan Healthcare Conference
Provider: Roth Capital Partners, Inc.
Analyst: RAHIMI Y
Company: Enanta Pharmaceuticals, Inc.
Industry: Medical - Drugs
Agenda for Our First Annual NASH Investor Conference on April 3 in NY
Provider: H.C. Wainwright & Co., Inc.
Analyst: ARCE E